Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction.

Su Yeong Park,Min Gyu Kong,Inki Moon,Hyun Woo Park,Hyung-Oh Choi,Hye Sun Seo,Yoon Haeng Cho,Nae-Hee Lee,Kwan Yong Lee,Ho-Jun Jang,Je Sang Kim,Ik Jun Choi,Jon Suh

The Korean journal of internal medicine（2023）

引用 0|浏览5

暂无评分

摘要

The de novo HF group had a lower risk of the primary composite outcome than the prior HF group in patients with reduced ejection fraction who were treated with ARNI.

查看译文

关键词

Angiotensin receptor-neprilysin inhibitor, Heart failure, Clinical outcome, Cardiac reverse remodeling, Worsening heart failure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要